Next Article in Journal
Glide Path in Endodontics: A Literature Review of Current Knowledge
Next Article in Special Issue
Correlation between Implant Surface Roughness and Implant Stability: A Systematic Review
Previous Article in Journal
Multibraided Fixed Retainers with Different Diameters after Magnetic Resonance Imaging (MRI): In Vitro Study Investigating Temperature Changes and Bonding Efficacy
Previous Article in Special Issue
Clinical Factors on Dental Implant Fractures: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cone Beam Computed Tomography Panoramic Mandibular Indices in the Screening of Postmenopausal Women with Low Bone Mass: Correlations with Bone Quantity and Quality

by
Ioana Ruxandra Poiană
1,
Iulia Florentina Burcea
2,3,*,
Silviu-Mirel Pițuru
1 and
Alexandru Bucur
1
1
Faculty of Dentistry, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
2
Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
3
Department of Endocrinology, National Institute of Endocrinology C. I. Parhon, 011853 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Dent. J. 2024, 12(8), 256; https://doi.org/10.3390/dj12080256
Submission received: 17 June 2024 / Revised: 3 August 2024 / Accepted: 9 August 2024 / Published: 14 August 2024
(This article belongs to the Special Issue Risk Factors in Implantology)

Abstract

:
Objective. This study examined the potential use of computed tomography panoramic mandibular indices on cone beam CT (CBCT) for assessing bone density in postmenopausal women with low bone mass. Study design. The study enrolled 104 postmenopausal women who underwent dual-energy X-ray absorptiometry (DXA) using a DXA scanner and mental foramen region CBCT alongside the NewTom VGi EVO Cone Beam 3D system. We assessed the relationship between the following DXA parameters: lumbar, femoral neck, and total hip T score, bone mineral density (BMD), and lumbar trabecular bone score (TBS). The following panoramic mandibular indices were also considered: the computed tomography mandibular index superior (CTI(S)), computed tomography mandibular index inferior (CTI(I)), and computed tomography mental index (CTMI). Results. The study revealed moderate correlations between CBCT indices and BMD/TBS scores: CTMI showed the highest correlation with the femoral neck T-score (r = 0.551, p < 0.0001). TBS scores were also moderately correlated with CBCT indices: CTMI showed a moderate positive correlation with TBS (r = 0.431, p < 0.0001); CTI(S) had a similar moderate positive correlation with TBS (r = 0.421, p < 0.0001). AUC values ranged from 0.697 to 0.733 for osteoporosis versus the osteopenia/normal group and from 0.734 to 0.744 for low versus normal bone quality groups, p < 0.0001. The comparison of the values of the studied indices between low versus normal bone quality (quantified with TBS) groups showed high sensitivity but low specificity. Conclusions. CBCT-measured indices CTI(S), CTI(I), and CTMI are useful in assessing patients with low bone mass to improve, by specific treatment, the prognosis of dental implants.

1. Introduction

First defined in 1993, osteoporosis is a widespread bone condition marked by reduced bone density and the structural weakening of bone tissue, leading to heightened bone fragility and an increased risk of fractures [1,2]. Although this condition can affect almost any person from any age group, postmenopausal women are a population “at-risk” of suffering from osteoporosis, mainly because of the changes in estrogen levels [3]. For the measurement of bone mineral density (BMD), dual-energy-X-ray absorptiometry (DXA) is the gold standard for the diagnosis of osteoporosis [4] and is defined as follows, according to the American Association Of Clinical Endocrinologists and American College Of Endocrinology (AACE/ACE) Clinical Practice Guidelines criteria: a. T-score –2.5 or below in the lumbar spine, femoral neck, total, and/or 33% (one-third) radius; b. low-trauma spine or hip fracture (regardless of BMD); c. osteopenia or low bone mass (T-score between −1 and −2.5) with fragility fracture of the proximal humerus, pelvis, or possibly distal forearm; and/or d. low bone mass or osteopenia and high FRAX® fracture probability based on country-specific thresholds [5].
The threshold for diagnosing osteoporosis based on BMD is important for clinical assessment and treatment, but although it is the best tool to predict fracture risk, it has several limitations that reduce its effectiveness in identifying patients who will eventually experience a fracture [1,6].
Knowing that there might be a significant correlation between the BMD of the mandible and that in the femoral neck and lumbar spine measured in patients with osteoporosis [7,8], some tools like cone beam computed tomography (CBCT), which assesses jaw bone density and quality might be used to evaluate BMD in patients with low bone mass [9,10]. Barra et al. [9] stated that radiomorphometric indices measured in specific centers from mental foramina are promising tools in CBCT of the mandible for assessing the BMD postmenopause, exhibiting significant differences among patients with normal BMD and the ones with osteopenia and/or osteoporosis. Similarly, Koh et al. [8] reported that specific indices on CBCT axial, sagittal, and coronal images are useful methods for osteoporosis screening. These panoramic quantitative indices are the most used method to evaluate low bone mass in the mental foramina region. By using superior and inferior cortical indices (CTI(S) and CTI(I)), significant differences were found between women with normal bone mass and those with osteoporosis (p < 0.05). The present study highlighted the effectiveness of these CBCT-derived indices in distinguishing between varying levels of bone mass and assessing the above-mentioned mandibular CBCT indices in primary osteoporosis with regard to both quantity and quality.
The evaluation of bone mass before dental implants is valuable for prognosis because the identification of patients with low bone mass and performing specific treatment can increase implant survival and stability.

2. Materials and Methods

This study was performed on postmenopausal women. Written informed consent was obtained from patients before the study. The study was approved by the Ethics Committee of “C. I. Parhon” National Institute of Endocrinology, Bucharest, Romania.
The inclusion criteria were as follows: female sex; aged more than 50 years; DXA with TBS evaluation; biological evaluation; and CBCT evaluation. The exclusion criteria were as follows: the presence of systemic diseases affecting bone metabolisms, such as neoplasia, osteomalacia/history of rickets, endocrine disorders (hyperthyroidism, hyperparathyroidism, Cushing’s syndrome, or acromegaly), severe renal failure, liver failure, or malabsorption disorders (Crohn disease, celiac disease); the presence of rheumatologic diseases (rheumatoid arthritis, ankylosing spondylitis), a history of oophorectomy; and the use of medications interfering with bone turnover/density (glucocorticoids, aromatase inhibitors, selective serotonin reuptake inhibitors, medroxyprogesterone acetate, antiepileptic drugs, unfractionated heparin).
The patients included were candidates for dental implants, and they performed CBCT as part of the pre-implant protocol, with the CBCT evaluation being commonly used in most of the dental clinics in a personalized implant protocol. The patients were evaluated in close collaboration with a private provider of dental imaging with expertise in CBCT imaging and the National Institute of Endocrinology, which is a public hospital that attends hundreds of patients with metabolic bone disease yearly. The enrolment period was between April 2021 and April 2024, with a maximum distance of 2 months between CBCT and DXA evaluations.
The included postmenopausal women had normal BMD, osteopenia, or osteoporosis, with or without antiresorptive/anabolic treatment.
Written informed consent was obtained from the patients before the study. The study was approved by the Ethics Committee of “C. I. Parhon” National Institute of Endocrinology, Bucharest, Romania (no. 4/8 April 2021).

2.1. CBCT Measurements

According to the modified Ledgerton’s classification [11], we used the following panoramic mandibular indices: CTI(S), CTI(I), and CTMI, defined as follows:
  • CTI(S): superior CT mandibular index (the ratio of the inferior cortical width to the distance from the superior margin of the mental foramen to the inferior mandibular border);
  • CTI(I): inferior CT mandibular index (the ratio of the inferior cortical width to the distance from the inferior margin of the mental foramen to the inferior mandibular border);
  • CTMI: CT mental index (the inferior mandibular cortical width).
The measurements of S, I, and W indices were performed on coronal images. The W index represents the inferior cortical width of the mandible; the S index represents the distance from the superior margin of the mental foramen to the inferior mandibular border; the I index represents the distance from the inferior margin of the mental foramen to the inferior mandibular border (Table 1). The measurements were performed by an experienced radiologist.
The CBCT images were obtained using NewTom VGi EVO Cone Beam 3D Imaging (CEFLA s.c.—Via Selice Provinciale 23/a, Imola, Italy) at 110 kV, 7.5 mA, 3.5 s, with a pixel size 0.2 mm. The images were reconstructed using NewTom NNT (ISDP©10003:2020 compliant in accordance with EN ISO/IEC 17065:2012 certificate number 2019003109-2) with Viewer software, version 16.0.

2.2. Bone Mineral Density Measurements

BMD was measured at the lumbar spine (LS), femoral neck (FN), and total hip by DXA (General Electric Prodigy Lunar, Bedford, UK) using enCore Software 10,50,086. BMD was expressed in grams per square centimeter (g/cm2), and, by comparing the BMD with the peak bone mass of a young adult, a T-score was obtained, expressed in standard deviations (SDs) and a Z-score for age-matched SDs. All measurements were performed according to the International Society for Clinical Densitometry (ISCD) [12]
TBS values were obtained by analyzing the L1–L4 vertebrae DXA images with iNsight Software version 2.2.0.0 (Medimaps Group SA Headquarters, Geneva, Switzerland).
All patients were scanned on the same DXA machine, yet by two different operators, thus allowing a user bias.

3. Statistical Analysis

We statistically analyzed the patients based on the value of the BMD (lumbar spine, femoral neck, total hip scores) and T score (lumbar spine, femoral neck, total hip scores), respectively, and TBS as continuous values, regardless of the osteoporosis diagnosis at the time of the CBCT evaluation.
Alternatively, we used binary logistic analysis to divide the patients based on osteoporosis diagnosis (according to AACE/ACE criteria) [5]. We also employed the regression analysis, the t-test, Pearson’s correlation coefficient, and Spearman’s rho, using IBM SPSS Statistics, version 25 (SPSS Inc, Chicago, IL, USA) for Mac OS.

4. Results

The characteristics of the patients included in the study are presented in the table below (Table 2). We included 104 postmenopausal women in this study with a mean age of 65.15 ± 9.12 years old. The mean age for menopause was 47.22 ± 5.3 years old, with a mean body mass index (BMI) of 26.58 ± 7.48. The mean lumbar BMD score was 0.944 g/cm2 (0.544, 1.437) with a mean T lumbar score of −1.95 SD (−5.3, 2.1). For the femoral neck, the mean BMD score was 0.944 g/cm2 (0.554, 1.221) with a mean T score of −1.95 SD (−3.5, 1.3). The mean score of TBS was 1.284 g/cm2 ± 105.83 SD (1.062, 1.558).
The patients had significantly lower T scores and BMD values in the osteoporosis group compared to the normal/osteopenia group.
Table 3 lists the mean values of the CBCT parameters depending on the bone quantity (assessed with lumbar and femoral neck T-scores) and bone quality (assessed with TBS). There were statistically significant differences based on bone quality and quantity, with higher values of the studied CBCT parameters observed in patients with a higher T score and higher TBS (p < 0.0001). Postmenopausal women with normal bone quality also show higher CTMI values (see Table 3). The values of CTI(S) were higher for patients with intermediate and normal bone quality.
Statistically significant correlations were also observed between bone quantity; this time, it was expressed as the linear value using the lumbar, femoral neck, and total hip BMD, not just using the T-score from the three mentioned regions. This emphasizes the importance of BMD to assess bone quantity more than just the T-score (Table 4). All CBCT parameters were moderately correlated (with the highest correlation coefficient being 0.551 for the CTMI with a femoral neck T-score; see Table 4). Using Pearson’s correlation coefficient and Spearman’s rho, we found the same moderate correlation between CBCT indices and bone mass (Table 5).
This study revealed moderate correlations between CBCT indices and BMD/TBS scores. Specifically,
  • CTMI showed the highest correlation with the femoral neck T-score (r = 0.551, p < 0.0001).
  • CTI(S) and CTI(I) also displayed significant correlations with T-scores and BMD measurements across various sites (lumbar spine, femoral neck, and total hip), with correlation coefficients ranging from 0.322 to 0.522 (p < 0.0001).
  • TBS scores were also moderately correlated with CBCT indices, with CTMI having a correlation coefficient of 0.431 (p < 0.0001).
Using regression analysis (linear and logistic), we list in Table 6 and Table 7 the prediction power of the studied CBCT parameters for assessing bone mass. We found that CTMI, CTI(I), and CTI(S) were effective in predicting bone quality and quantity (p < 0.0001). In the logistic regression analysis, all models reached statistical significance (see Table 7).
ROC analyses for the pair-wise comparisons between the groups are illustrated in Figure 1 and Figure 2. The AUC values, 95% CI, sensitivity, specificity, and cut-off points of cortical thickness are listed in Table 6. The comparison between individuals based on the T score value (lumbar, and/or femoral neck and/or total hip) with osteoporosis (T score ≤ −2.5 SD) and osteopenia/normal value (T-score > −2.5 SD) yielded an AUC between 0.697 and 0.733 (see Figure 1). The cut-offs are presented in Table 8, with a sensitivity between 63.8% and 67.2% and a specificity of 27.5%.
The comparison between individuals based on TBS (expressed as low if TBS ≤1.31 g/cm2 and normal if TBS > 1.31 g/cm2) yielded an AUC between 0.734 and 0.744 (see Figure 2). The cut-offs are presented in Table 8, with a sensitivity between 84.8% and 90.9% and a specificity between 33.3% and 43.8%.

5. Discussion

This study examined the use of computed tomography panoramic mandibular indices on CBCT images for the evaluation of BMD in postmenopausal women. The results demonstrated that CTMI, CTI(S), and CTI(I) are tools that can be used in mandibular CBCT for the assessment of bone mass in postmenopausal women; these indices exhibit significant differences among this category of patients depending on the bone mass quantity and quality evaluated on DXA scan.
The lowest T score observed in this study is for the lumbar spine in the context of the rich trabecular bone content in this area, which is more susceptible to bone changes [13]. The use of all validated DXA sites and comparing patients with normal/osteopenia/osteoporosis status rather than comparing only osteoporosis patients with normal bone mass [9,14] enhances the depth of the present results. Assessing bone quality through the trabecular bone score offers insights into bone micro-architecture beyond just bone quantity, making it a valuable tool for evaluating bone health in cases of both primary and secondary osteoporosis.
The study found significant correlations between the panoramic mandibular indices and lumbar T-scores. The computed tomography mental index (CTMI), computed tomography mandibular index superior (CTI(S)), and computed tomography mandibular index inferior (CTI(I)) showed the following Pearson correlation coefficients with lumbar T-scores as follows: CTMI: r = 0.429, p < 0.0001; CTI(S): r = 0.387, p < 0.0001; CTI(I): r = 0.364, p < 0.0001. These results indicate a moderate positive correlation, suggesting that as the lumbar T-score increases, indicating higher bone density, the values of the mandibular indices also tend to increase. The correlations with femoral neck T-scores were even stronger. The higher correlation coefficients reflect a stronger relationship between mandibular indices and femoral neck bone density compared to the lumbar spine. Similarly, total hip T-scores also showed significant correlations. These findings align with the scores from Koh and colleagues [8,15], who reported that these CBCT indices could be effective for osteoporosis screening and the evaluation of bone quality in postmenopausal women.
The findings of the study suggest that mandibular indices might be particularly sensitive to changes in the bone density of the femoral neck, considering that the highest correlation was observed between CTMI and femoral neck T-scores. In a study by Munhoz et al. [16], significant correlations were found between mandibular cortical width and BMD. This study corroborates the present findings, particularly regarding the strong correlation between CTMI and femoral neck BMD, reinforcing the potential of mandibular indices as indicators of overall bone health. Barra et al. [17] also found significant differences in mandibular radiomorphometric indices among patients with normal BMD or a low bone mass. Their results on 48 postmenopausal women emphasized the potential of CBCT measurements to reflect systemic bone density changes.
TBS is a relatively new metric derived from lumbar DXA scans. Unlike BMD, which measures bone mineral density, TBS provides an indirect assessment of the trabecular micro-architecture. It is a valuable tool in evaluating bone micro-architecture and predicting fracture risk as it reflects the structural integrity of trabecular bone, which is crucial in understanding bone strength and fragility. The current study explored the correlation between CBCT-derived mandibular indices and TBS. The key findings are as follows: CTMI showed a moderate positive correlation with TBS (r = 0.431, p < 0.0001); CTI(S) had a similar moderate positive correlation with TBS (r = 0.421, p < 0.0001); CTI(I) also correlated with TBS, albeit slightly lower than the other two indices (r = 0.351, p < 0.0001). These correlations indicate that higher mandibular index values, as measured by CBCT, are associated with better trabecular bone quality, as indicated by TBS scores. Diba SF et al. [18] stated that the depletion of the trabeculae bone structure is much clearer in osteoporotic postmenopausal women; thus, the initial bone quality assessment can be performed using trabecular thickness parameters. However, in their study, they used dental radiographs as the bone quality screening tool. This is the first study to correlate TBS with panoramic mandibular CBCT indices regarding the assessment of bone micro-architecture (a parameter of bone quality) in postmenopausal women.
The comparison of the studied indices between the low and normal bone quality groups (quantified with TBS) demonstrated high sensitivity with a low chance of false-negative results. The low specificity indicates a high probability of false positive results. In contrast, the comparison of mean values of the indices between osteoporosis and normal BMD/osteopenia groups revealed lower sensitivity, suggesting a higher possibility of false-negative results.
This study highlights some of the limitations of DXA, including its ineffectiveness in predicting fractures accurately. Although it remains the gold standard in the diagnosis of osteoporosis [19], the published literature [12,20] has noted that a significant limitation of BMD measurements is that most fragility fractures occur at non-osteoporotic BMD levels (T-scores > −2.5), which undermines its effectiveness as a screening tool [12]. A prospective study from 2024 performed by Sornay-Rendu et al. [21] used high-resolution peripheral computed tomography (HR-pQCT) to evaluate the micro-architecture of the radius in almost 600 postmenopausal women. It found that even patients with a normal BMD who experience fragility fractures have altered bone micro-architecture. In a study from the same year by Li et al. [13], who also used QCT to evaluate the predictive value of thoracic trabecular BMD, it was found that this correlated with the risk of future hip and vertebral fractures, with most of the patients exhibiting underdiagnosed low bone mass (osteopenia/osteoporosis).
Another imaging exam that can be useful for the maxillofacial region is magnetic resonance imaging (MRI) [22]. While CBCT is the standard imaging for the maxillofacial bone area, MRI can provide comparable results [23], although it can slightly overestimate bone parameters [24]. Some studies have reported similar bone results when using MRI and other imaging techniques such as CT and CBCT [23]. In addition, one study found a weak correlation between MRI and CBCT scan values [24]. The differences between MRI and CBCT are measurable concerning spatial resolution or image contrast, thus affecting the detection of discrete changes in bone morphology or trabecular arrangement [22].
Our findings suggest that recognizing the potential role of CBCT in assessing bone mass could enhance the early detection and management of osteoporosis in postmenopausal women. Thus, the patients can be treated in order to increase bone mass and improve bone micro-architecture, enabling the clinician to provide a more precise, patient-specific prognosis for future implant success rather than relying on the typical summary evaluation. Since CBCT can be more accessible and less cumbersome than DXA, it offers a practical approach for widespread osteoporosis screening in addition to existing tools, especially when considering the increased use of this tool in the general population. This is particularly important given the increasing prevalence of osteoporosis among aging populations.

6. Conclusions

The findings of this study suggest that CBCT-derived mandibular indices can be reliable indicators of low bone mass in postmenopausal women. These indices could potentially be integrated into routine dental assessments, providing an accessible screening tool for osteoporosis. This is important to evaluate bone mass before the dental implant and treatment accordingly to obtain a stable implant site and increase its prognosis.
Future research should aim to validate these findings in larger, more diverse populations, explore the longitudinal predictive value of these indices for fracture risk, and investigate the cost-effectiveness and practical implementation of CBCT screenings in clinical practice.

Author Contributions

Conceptualization, I.R.P. and I.F.B.; methodology, I.R.P., I.F.B.; S.-M.P. and A.B.; software, I.R.P. and I.F.B.; validation, I.R.P., I.F.B., and A.B.; formal analysis, I.R.P. and I.F.B.; investigation, I.R.P. and I.F.B.; resources, I.R.P., I.F.B., and A.B.; data curation I.F.B.; writing—original draft preparation, I.R.P. and I.F.B.; writing—review and editing, I.F.B. and A.B.; visualization, I.F.B. and A.B.; supervision, A.B.; project administration, I.R.P., I.F.B., and A.B. All authors have read and agreed to the published version of the manuscript.

Funding

The publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila through the institutional program Publish not Perish.

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of “C. I. Parhon” National Institute of Endocrinology, Bucharest, Romania (protocol number 4/8 April 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Schini, M.; Johansson, H.; Harvey, N.C.; Lorentzon, M.; Kanis, J.A.; McCloskey, E.V. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J. Endocrinol. Investig. 2024, 47, 501–511. [Google Scholar] [CrossRef] [PubMed]
  2. Adejuyigbe, B.; Kallini, J.; Chiou, D.; Kallini, J.R. Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. Int. J. Mol. Sci. 2023, 24, 14583. [Google Scholar] [CrossRef] [PubMed]
  3. Bhatnagar, A.; Kekatpure, A.L. Postmenopausal Osteoporosis: A Literature Review. Cureus 2022, 14, e29367. [Google Scholar] [CrossRef] [PubMed]
  4. On the Prevention WHOSG of Osteoporosis. Prevention and Management of Osteoporosis: Report of a WHO Scientific Group; WHO technical report series; 921; World Health Organization: Geneva, Switzerland, 2003; p. 192. [Google Scholar]
  5. Camacho, P.M.; Petak, S.M.; Binkley, N.; Clarke, B.L.; Harris, S.T.; Hurley, D.L.; Kleerekoper, M.; Lewiecki, E.M.; Miller, P.D.; Narula, H.S.; et al. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016. Endocr. Pract. 2016, 22, 1111–1118. [Google Scholar] [CrossRef] [PubMed]
  6. Kanis, J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos. Int. 1994, 4, 368–381. [Google Scholar] [CrossRef] [PubMed]
  7. Taguchi, A.; Tsuda, M.; Ohtsuka, M.; Kodama, I.; Sanada, M.; Nakamoto, T.; Inagaki, K.; Noguchi, T.; Kudo, Y.; Suei, Y.; et al. Use of dental panoramic radiographs in identifying younger postmenopausal women with osteoporosis. Osteoporos. Int. 2006, 17, 387–394. [Google Scholar] [CrossRef] [PubMed]
  8. Koh, K.-J.; Kim, K.-A. Utility of the computed tomography indices on cone beam computed tomography images in the diagnosis of osteoporosis in women. Imaging Sci. Dent. 2011, 41, 101–106. [Google Scholar] [CrossRef] [PubMed]
  9. Barra, S.G.; Gomes, I.P.; Amaral, T.M.P.; Brasileiro, C.B.; Abreu, L.G.; Mesquita, R.A. New mandibular indices in cone beam computed tomography to identify low bone mineral density in postmenopausal women. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2021, 131, 347–355. [Google Scholar] [CrossRef]
  10. Alshomrani, F. Cone-Beam Computed Tomography (CBCT)-Based Diagnosis of Dental Bone Defects. Diagnostics 2024, 14, 1404. [Google Scholar] [CrossRef] [PubMed]
  11. Ledgerton, D.; Horner, K.; Devlin, H.; Worthington, H. Panoramic mandibular index as a radiomorphometric tool: An assessment of precision. Dentomaxillofac. Radiol. 1997, 26, 95–100. [Google Scholar] [CrossRef]
  12. Lewiecki, E.M.; Binkley, N.; Morgan, S.L.; Shuhart, C.R.; Camargos, B.M.; Carey, J.J.; Gordon, C.M.; Jankowski, L.G.; Lee, J.-K.; Leslie, W.D. Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance. J. Clin. Densitom. 2016, 19, 127–140. [Google Scholar] [CrossRef] [PubMed]
  13. Li, D.; Mao, S.S.; Budoff, M.J. Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: The multi-ethnic study of atherosclerosis. Osteoporos. Int. 2024, 35, 1061–1068. [Google Scholar] [CrossRef] [PubMed]
  14. Francisco, I.; Nunes, C.; Pereira, F.; Travassos, R.; Ribeiro, M.P.; Marques, F.; McEvoy, M.; Santos, M.; Oliveira, C.; Marto, C.M.; et al. Bone Mineral Density through DEXA and CBCT: A Systematic Review with Meta-Analysis. Appl. Sci. 2023, 13, 5962. [Google Scholar] [CrossRef]
  15. Koh, K.K.; Tan, J.S.; Nambiar, P.; Ibrahim, N.; Mutalik, S.; Khan Asif, M. Age estimation from structural changes of teeth and buccal alveolar bone level. J. Forensic Leg. Med. 2017, 48, 15–21. [Google Scholar] [CrossRef] [PubMed]
  16. Diba, S.F.; Gracea, R.S.; Shantiningsih, R.R.; Hidjah, K. Analysis of mandible trabecular structure using digital periapical radiographs to assess low bone quality in postmenopausal women. Saudi Dent. J. 2021, 33, 997–1003. [Google Scholar] [CrossRef]
  17. Munhoz, L.; Morita, L.; Nagai, A.Y.; Moreira, J.; Arita, E.S. Mandibular cortical index in the screening of postmenopausal at low mineral density risk: A systematic review. Dentomaxillofac. Radiol. 2021, 50, 20200514. [Google Scholar] [CrossRef] [PubMed]
  18. Daly, A.F.; Tichomirowa, M.A.; Petrossians, P.; Heliövaara, E.; Jaffrain-Rea, M.-L.; Barlier, A.; Naves, L.A.; Ebeling, T.; Karhu, A.; Raappana, A.; et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study. J. Clin. Endocrinol. Metab. 2010, 95, E373–E383. [Google Scholar] [CrossRef] [PubMed]
  19. Sornay-Rendu, E.; Duboeuf, F.; Chapurlat, R.D. Postmenopausal women with normal BMD who have fractures have deteriorated bone microarchitecture: A prospective analysis from The OFELY study. Bone 2024, 182, 117072. [Google Scholar] [CrossRef] [PubMed]
  20. Parize, H.; Sadilina, S.; Caldas, R.A.; Cordeiro, J.V.C.; Kleinheinz, J.; Laganá, D.C.; Sesma, N.; Bohner, L. Magnetic resonance imaging for jawbone assessment: A systematic review. Head Face Med. 2024, 20, 25. [Google Scholar] [CrossRef]
  21. de Fuglsig, J.M.C.E.S.; Hansen, B.; Schropp, L.; Nixdorf, D.R.; Wenzel, A.; Spin-Neto, R. Alveolar bone measurements in magnetic resonance imaging compared with cone beam computed tomography: A pilot, ex-vivo study. Acta Odontol. Scand. 2023, 81, 241–248. [Google Scholar] [CrossRef]
  22. Bohner, L.; Tortamano, P.; Meier, N.; Gremse, F.; Kleinheinz, J.; Hanisch, M. Trabecular Bone Assessment Using Magnetic-Resonance Imaging: A Pilot Study. Int. J. Environ. Res. Public Health 2020, 17, 9282. [Google Scholar] [CrossRef] [PubMed]
  23. Flügge, T.; Hövener, J.-B.; Ludwig, U.; Eisenbeiss, A.-K.; Spittau, B.; Hennig, J.; Schmelzeisen, R.; Nelson, K. Magnetic resonance imaging of intraoral hard and soft tissues using an intraoral coil and FLASH sequences. Eur. Radiol. 2016, 26, 4616–4623. [Google Scholar] [CrossRef] [PubMed]
  24. Choi, I.G.G.; Pinhata-Baptista, O.H.; Ferraço, R.; Kim, J.H.; Abdala Júnior, R.; Arita, E.S.; Cortes, A.R.G.; Ackerman, J.L. Correlation among alveolar bone assessments provided by CBCT, micro-CT, and 14 T MRI. Dentomaxillofac. Radiol. 2022, 51, 20210243. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Receiver operator characteristic (ROC) analyses for the pair-wise comparisons of indices in patients with osteoporosis and osteopenia/normal BMD. (A)—comparison of CTI(S) index between individuals with T score −2.5 SD versus > −2.5 SD; (B)—comparison of CTI(I) index between individuals with T score −2.5 SD versus > −2.5 SD; and (C)—comparison of CTMI index between individuals with T score −2.5 SD versus > −2.5 SD; osteoporosis diagnosed based on T score values in specific sites, osteoporosis if ≤−2.5 SD and osteopenia/normal if >−2.5 SD; BMD, bone mass density; expressed as g/cm2; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Figure 1. Receiver operator characteristic (ROC) analyses for the pair-wise comparisons of indices in patients with osteoporosis and osteopenia/normal BMD. (A)—comparison of CTI(S) index between individuals with T score −2.5 SD versus > −2.5 SD; (B)—comparison of CTI(I) index between individuals with T score −2.5 SD versus > −2.5 SD; and (C)—comparison of CTMI index between individuals with T score −2.5 SD versus > −2.5 SD; osteoporosis diagnosed based on T score values in specific sites, osteoporosis if ≤−2.5 SD and osteopenia/normal if >−2.5 SD; BMD, bone mass density; expressed as g/cm2; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Dentistry 12 00256 g001
Figure 2. Receiver operator characteristic (ROC) analyses for the pair-wise comparisons of indices in patients with low versus normal bone quality based on TBS. (A)—comparison of CTI(S) index between individuals with low versus normal bone quality, based on TBS; (B)—comparison of CTI(I) index between individuals with low versus normal bone quality based on TBS; and (C)—comparison of CTMI index between individuals low versus normal bone quality, based on TBS; trabecular bone score, expressed as low if TBS ≤ 1.31 g/cm2, and normal if TBS > 1.31 g/cm2; TBS, trabecular bone score; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Figure 2. Receiver operator characteristic (ROC) analyses for the pair-wise comparisons of indices in patients with low versus normal bone quality based on TBS. (A)—comparison of CTI(S) index between individuals with low versus normal bone quality, based on TBS; (B)—comparison of CTI(I) index between individuals with low versus normal bone quality based on TBS; and (C)—comparison of CTMI index between individuals low versus normal bone quality, based on TBS; trabecular bone score, expressed as low if TBS ≤ 1.31 g/cm2, and normal if TBS > 1.31 g/cm2; TBS, trabecular bone score; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Dentistry 12 00256 g002
Table 1. Indices and their significance.
Table 1. Indices and their significance.
IndexValue
CTI(S)W/S
CTI(I)W/I
CTMIW
W—inferior cortical width of the mandible; S—distance from the superior margin of the mental foramen to the inferior mandibular border; and I—distance from the inferior margin of the mental foramen to the inferior mandibular border.
Table 2. Patients’ distribution.
Table 2. Patients’ distribution.
ParameterT score ≤ −2.5 *T score ≥ −2.5 *
Number4559
BMI (kg/m2)24.47 ± 4.9127.66 ± 8.38
Age at menopause (years)47.18 ± 4.4947.43 ± 5.73
Femoral neck T score (SD)−2.06 ± 0.66−1.15 ± 0.85
Total hip T score (SD)−1.67 ± 0.78−0.6 ± 1.04
Lumbar T score (L1-L4) (SD)−3.12 ± 0.69−1.3 ± 0.92
Femoral neck BMD (g/cm2)0.727 ± 0.0820.852 ± 0.11
Total hip BMD (L1-L4) (g/cm2)0.713 ± 0.3660.941 ± 0.132
Lumbar BMD (g/cm2)0.805 ± 0.0881.018 ± 0.012
TBS score (g/cm2)1207 ± 1811313 ± 100.9
* The values are expressed as the mean ± SD but did not include patients with osteoporosis based on other AACE criteria.
Table 3. Mean values of the computed tomography parameters on cone beam computed tomography (CBCT) images.
Table 3. Mean values of the computed tomography parameters on cone beam computed tomography (CBCT) images.
CBCT ParameterLumbar T-Score > −2.5 SD (n = 62)Lumbar T-Score ≤ −2.5 SD (n = 42)Femoral Neck T-Score > −2.5 SD (n = 85)Femoral Neck T-Score ≤ −2.5 SD (n = 14)Low Bone Quality (TBS ≤ 1.23, n = 21)Intermediate Bone Quality (TBS > 1.23 and <1.31, n = 32)Normal Bone Quality
(TBS ≥ 1.31, n = 33)
p Value
CTMI2.74 ± 0.802.43 ± 0.832.72 ± 0.741.84 ± 0.682.12 ± 0.612.42 ± 0.843.04 ± 0.69p < 0.0001
CTI(I)0.24 ± 0.070.21 ± 0.070.24 ± 0.060.17 ± 0.060.20 ± 0.060.21 ± 0.070.26 ± 0.05p < 0.0001
CTI(S)0.18 ± 0.050.16 ± 0.050.18 ± 0.050.13 ± 0.06 0.14 ± 0.040.16 ± 0.050.20 ± 0.04p < 0.0001
TBS, trabecular bone score; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Table 4. Correlations between CBCT parameters and bone quantity and quality parameters.
Table 4. Correlations between CBCT parameters and bone quantity and quality parameters.
Parameters for Correlations CTMICTI(S)CTI(I)
Lumbar T score *0.429, p < 0.00010.387, p < 0.00010.364, p < 0.0001
Femoral neck T score *0.551, p < 0.00010.465, p < 0.00010.481, p < 0.0001
Total hip T score *0.470, p < 0.00010.440, p < 0.00010.451, p < 0.0001
TBS score *0.431, p < 0.00010.421, p < 0.00010.351, p < 0.0001
TBS quality assessment ***0.454, p < 0.00010.379, p < 0.00010.423, p < 0.001
Lumbar BMD **0.359, p < 0.00010.355, p < 0.00010.322, p < 0.0001
Femoral neck BMD **0.522, p < 0.00010.443, p < 0.00010.446, p < 0.0001
Total hip BMD **0.509, p < 0.00010.445, p < 0.00010.460, p < 0.0001
Osteoporosis defined as lumbar T-score ≤ −2.5 SD−0.387, p < 0.0001−0.296, p = 0.003−0.349, p < 0.0001
Significant at the 0.05 level t-test (2-tailed); * expressed as standard deviations; ** bone mass density, expressed as g/cm2; *** trabecular bone score, expressed as low if TBS ≤1.23, intermediate if TBS > 1.23 and <1.31, and normal if TBS > 1.31; TBS, trabecular bone score; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computed tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Table 5. CBCT parameters, bone quantity, and quality parameters using Pearson’s correlation coefficient and Spearman’s rho.
Table 5. CBCT parameters, bone quantity, and quality parameters using Pearson’s correlation coefficient and Spearman’s rho.
Pearson’s Correlation CTMI, (n = 104)CTI(S), (n = 104)CTI(I), (n = 103)
Lumbar T score *0.429, p < 0.00010.387, p < 0.00010.364, p < 0.0001
Femoral neck T score *0.551, p < 0.00010.465, p < 0.00010.481, p < 0.0001
Total hip T score *0.470, p < 0.00010.440, p < 0.00010.451, p < 0.0001
TBS score *0.431, p < 0.00010.421, p < 0.00010.351, p < 0.001
TBS quality assessment ***0.454, p < 0.00010.423, p < 0.00010.379 p < 0.0001
Lumbar BMD **0.359, p < 0.00010.355, p < 0.00010.322, p < 0.001
Femoral neck BMD **0.522, p < 0.00010.443, p < 0.00010.523, p < 0.0001
Total hip BMD **0.509, p < 0.00010.445, p < 0.00010.481, p < 0.0001
Osteoporosis defined
as lumbar T score ≤ −2.5 SD
−0.185, p = 0.06−0.176, p = 0.073−0.675, p < 0.0001
Osteoporosis defined
as femoral neck T score ≤ −2.5 SD
−0.387, p < 0.0001−0.296, p < 0.0001−0.349, p < 0.0001
Spearman’s rhoCTMICTI-SCTI-I
Lumbar T score *0.439, p < 0.00010.386, p < 0.00010.380, p < 0.0001
Femoral neck T score *0.541, p < 0.00010.439, p < 0.00010.468, p < 0.0001
Total hip T score *0.476, p < 0.00010.435, p < 0.00010.449, p < 0.0001
TBS score *0.464, p < 0.00010.460, p < 0.00010.413, p < 0.0001
TBS quality assessment ***0.456, p < 0.00010.448, p < 0.00010.419, p < 0.0001
Lumbar BMD **0.397, p < 0.00010.371, p < 0.00010.363, p < 0.0001
Femoral neck BMD **0.493, p < 0.00010.393, p < 0.00010.416, p < 0.0001
Total hip BMD **0.518, p < 0.00010.450, p < 0.00010.473, p < 0.0001
Osteoporosis defined as lumbar T score ≤ −2.5 SD−0.224, p = 0.022−0.212, p = 0.031−0.225, p = 0.022
Osteoporosis defined as femoral neck T score ≤ −2.5 SD−0.379, p < 0.0001−0.284, p < 0.0001−0.328, p < 0.0001
Correlation is significant at the 0.01 and 0.05 level (2-tailed). * expressed as standard deviations; ** bone mass density, expressed as g/cm2; *** trabecular bone score, expressed as low if TBS ≤ 1.23, intermediate if TBS > 1.23 and <1.31, and normal if TBS > 1.31; TBS, trabecular bone score; SD, standard deviation; CBCT, cone-beam computer tomography; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; and CTI(S), superior computer tomography mandibular index.
Table 6. Predictions of osteoporosis and bone quality using regression analysis (linear regression).
Table 6. Predictions of osteoporosis and bone quality using regression analysis (linear regression).
ParametersVariableRegression ValueConstant of the ModelModel’s Sig.
Lumbar T score *CTMI0.70, p < 0.0001−3.76, p < 0.0001R2 = 0.18, p < 0.0001
Femoral neck T score *0.46, p < 0.0001−3.26, p < 0.0001R2 = 0.3, p < 0.0001
Total hip T score *0.336, p < 0.0001−2.99, p < 0.0001R2 = 0.22, p < 0.0001
TBS score *0.00033, p < 0.0001−0.0167 p = 0.09R2 = 0.18, p < 0.0001
Lumbar T score *CTI(S)1.56, p < 0.0001−2.00, p < 0.0001R2 = 0.15, p < 0.001
Femoral neck T score *2.61, p < 0.0001−2.09, p < 0.0001R2 = 0.21, p < 0.0001
Total hip T score *9.18, p < 0.0001−2.57, p < 0.0001R2 = 0.194, p < 0.0001
TBS score *0.0021, p < 0.0001−0.01, p = 0.113R2 = 0.177, p < 0.0001
Lumbar T score *CTI(I)6.97, p < 0.0001−3.52, p < 0.0001R2 = 0.13, p < 0.0001
Femoral neck T score *6.63, p < 0.0001−2.99, p < 0.0001R2 = 0.23, p < 0.0001
Total hip T score *7.3, p < 0.0001−2.67, p < 0.0001R2 = 0.20, p < 0.0001
TBS score *0.53, p = 0.0011.163 p < 0.0001R2 = 0.112, p < 0.0001
* expressed as standard deviations; bone mass density, expressed as g/cm2.
Table 7. Predictions of osteoporosis and bone quality using regression analysis (logistic regression).
Table 7. Predictions of osteoporosis and bone quality using regression analysis (logistic regression).
ParametersVariableOdds RatioModel’s Sig.
TBS quality assessment ***CTMI1.137, 95% CI (1.058, 1.222)p < 0.0001
Osteoporosis defined
as lumbar T score ≤ −2.5 SD
0.953, 95% CI (0.906, 1.003)p = 0.063
Osteoporosis defined as femoral neck T score ≤ −2.5 SD0.834, 95% CI (0.752, 0.924)p < 0.001
Osteoporosis based on AACE criteria **0.891, 95% CI (0.837, 0.948)p < 0.0001
TBS quality assessment ***CTI(S)1.20, 95% CI (1.081, 1.333)p < 0.0001
Osteoporosis defined
as lumbar T score ≤ −2.5 SD
0.934, 95% CI (0.866–1.007)p = 0.076
Osteoporosis defined as femoral neck T score ≤ −2.5 SD0.836, 95% CI (0.737, 0.949)p = 0.006
Osteoporosis based on AACE criteria **0.868, 95% CI (0.796, 0.946)p < 0.001
TBS quality assessment ***CTI(I)1.137, 95% CI (1.051, 1.230)p < 0.001
Osteoporosis defined
as lumbar T score ≤ −2.5 SD
0.946, 95% CI (0.892, 1.003)p = 0.063
Osteoporosis defined as femoral neck T score ≤ −2.5 SD0.847, 95% CI (0.765, 0.938)p < 0.0001
Osteoporosis based on AACE criteria **0.906 95% CI (0.849, 0.967)p < 0.0001
*** expressed as standard deviations. ** bone mass density, expressed as g/cm2.
Table 8. Assessment of the area under the curve, 95% confidence interval, sensitivity, specificity, cut-off points, and model significance.
Table 8. Assessment of the area under the curve, 95% confidence interval, sensitivity, specificity, cut-off points, and model significance.
Area under the Curve95% CISensitivitySpecificityCut off Point (mm)Model Significance
Comparison between individuals based on T score *
CTI(S)0.6970.588–0.80665.5%27.5%1.75p < 0.001
CTI(I)0.7090.602–0.81763.8%27.5%2.35p < 0.0001
CTMI0.7330.629–0.83667.2%27.5%2.75p < 0.0001
Comparison between individuals based on TBS *
CTI(S)0.7440.636–0.85290.9%43.8%1.55p < 0.0001
CTI(I)0.7340.628–0.84490.9%41.7%2.15p < 0.0001
CTMI0.7430.634–0.85284.8%33.3%2.70p < 0.0001
* T-score expressed as standard deviations, osteoporosis if ≤−2.5 SD, and osteopenia/normal if >−2.5 SD; bone mass density, expressed as g/cm2; trabecular bone score, expressed as low if TBS ≤ 1.31, and normal if TBS > 1.31. TBS, trabecular bone score; SD, standard deviation; CTMI, computer tomography mental index; CTI(I), inferior computer tomography mandibular index; CTI(S), superior computer tomography mandibular index; and CI, confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Poiană, I.R.; Burcea, I.F.; Pițuru, S.-M.; Bucur, A. Cone Beam Computed Tomography Panoramic Mandibular Indices in the Screening of Postmenopausal Women with Low Bone Mass: Correlations with Bone Quantity and Quality. Dent. J. 2024, 12, 256. https://doi.org/10.3390/dj12080256

AMA Style

Poiană IR, Burcea IF, Pițuru S-M, Bucur A. Cone Beam Computed Tomography Panoramic Mandibular Indices in the Screening of Postmenopausal Women with Low Bone Mass: Correlations with Bone Quantity and Quality. Dentistry Journal. 2024; 12(8):256. https://doi.org/10.3390/dj12080256

Chicago/Turabian Style

Poiană, Ioana Ruxandra, Iulia Florentina Burcea, Silviu-Mirel Pițuru, and Alexandru Bucur. 2024. "Cone Beam Computed Tomography Panoramic Mandibular Indices in the Screening of Postmenopausal Women with Low Bone Mass: Correlations with Bone Quantity and Quality" Dentistry Journal 12, no. 8: 256. https://doi.org/10.3390/dj12080256

APA Style

Poiană, I. R., Burcea, I. F., Pițuru, S. -M., & Bucur, A. (2024). Cone Beam Computed Tomography Panoramic Mandibular Indices in the Screening of Postmenopausal Women with Low Bone Mass: Correlations with Bone Quantity and Quality. Dentistry Journal, 12(8), 256. https://doi.org/10.3390/dj12080256

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop